{"disease":{"id":"hypoglobulinemia","name":"hypoglobulinemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04182737","title":"Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":356,"lead_sponsor_name":"Massimo Girardis","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}